ConductScience.org, home

Paper41454405

Long non-coding RNAs in the tumor immune microenvironment of non-small cell lung cancer: mechanisms and clinical translational perspectives.

Wang W and 6 others. J Transl Med, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Long non-coding RNAs in the tumor immune microenvironment of non-small cell lung cancer: mechanisms and clinical translational perspectives. Papers, record 41454405. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41454405

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long non-coding RNAs in the tumor immune microenvironment of non-small cell lung cancer: mechanisms and clinical translational perspectives.
PubMed
Journal
J Transl Med
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.13, provisional
iCite
Revised in PubMed
2026-09-10
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang WWeiwei
2Jiang ZZhibiao
3Zhao KKun
4Teng YYuanyin
5Wu LLingling
6Yu TTing
7Shang AAnquanhttps://orcid.org/0000-0003-2820-1982

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
RNA, Long NoncodingMajor topic
Carcinoma, Non-Small-Cell LungMajor topic
Tumor MicroenvironmentMajor topic
Lung NeoplasmsMajor topic
Translational Research, BiomedicalMajor topic
Humans
Animals
Immunotherapy

Source PubMed

Download CSV of topics

References88

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132259264Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer.JAMA Netw Open2020https://conductscience.org/library/papers/32259264PubMed
236706831Shiny transcriptional junk: lncRNA-derived peptides in cancers and immune responses.Life Sci2023https://conductscience.org/library/papers/36706831PubMed
38970741RGD and other recognition sequences for integrins.Annu Rev Cell Dev Biol1996https://conductscience.org/library/papers/8970741PubMed
437909877Screening for lung cancer: 2023 guideline update from the American Cancer Society.CA Cancer J Clin2024https://conductscience.org/library/papers/37909877PubMed
535658874Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis.Cell Mol Biol Lett2022https://conductscience.org/library/papers/35658874PubMed
633434533FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.Life Sci2021https://conductscience.org/library/papers/33434533PubMed
738572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
837146936Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer.Cancer Lett2023https://conductscience.org/library/papers/37146936PubMed
933674747LY6K-AS lncRNA is a lung adenocarcinoma prognostic biomarker and regulator of mitotic progression.Oncogene2021https://conductscience.org/library/papers/33674747PubMed
1038484655A comprehensive review of lncRNA CRNDE in cancer progression and pathology, with a specific glance at the epithelial-mesenchymal transition (EMT) process.Pathol Res Pract2024https://conductscience.org/library/papers/38484655PubMed
1137142269m6A-mediated upregulation of lncRNA-AC026356.1 promotes cancer stem cell maintenance in lung adenocarcinoma via activating Wnt signaling pathway.Aging (Albany NY)2023https://conductscience.org/library/papers/37142269PubMed
1235415876LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non-small cell lung cancer.Clin Transl Med2022https://conductscience.org/library/papers/35415876PubMed
1338574881LncRNA RGMB-AS1 inhibits HMOX1 ubiquitination and NAA10 activation to induce ferroptosis in non-small cell lung cancer.Cancer Lett2024https://conductscience.org/library/papers/38574881PubMed
1435117761LncRNA FENDRR-mediated tumor suppression and tumor-immune microenvironment changes in non-small cell lung cancer.Transl Cancer Res2020https://conductscience.org/library/papers/35117761PubMed
1533849634PD-L1 lncRNA splice isoform promotes lung adenocarcinoma progression via enhancing c-Myc activity.Genome Biol2021https://conductscience.org/library/papers/33849634PubMed
1636360316Radiosensitization-Related Cuproptosis LncRNA Signature in Non-Small Cell Lung Cancer.Genes (Basel)2022https://conductscience.org/library/papers/36360316PubMed
1735896612Evaluating the utility of an immune checkpoint-related lncRNA signature for identifying the prognosis and immunotherapy response of lung adenocarcinoma.Sci Rep2022https://conductscience.org/library/papers/35896612PubMed
1836147664Computational solutions for spatial transcriptomics.Comput Struct Biotechnol J2022https://conductscience.org/library/papers/36147664PubMed
1926433395Statistical controversies in clinical research: long-term follow-up of clinical trials in cancer.Ann Oncol2015https://conductscience.org/library/papers/26433395PubMed
2037380368PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis.J Immunother Cancer2023https://conductscience.org/library/papers/37380368PubMed

See all 88 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42582172Evolving non-invasive biomarkers in NSCLC immunotherapy: integrating liquid biopsy and multi-omics profiling for precision oncology.Front Immunol2026https://conductscience.org/library/papers/42582172PubMed
42500647Long non-coding RNAs and their potential role in predicting immunotherapy response and prognosis: a systematic review.Front Immunol2026https://conductscience.org/library/papers/42500647PubMed
42292412Tumor-immune crosstalk in lung cancer: emerging roles of long non-coding RNAs.Front Immunol2026https://conductscience.org/library/papers/42292412PubMed
42199421Negative regulators antagonizing antitumor innate immune pathways in lung cancer immune evasion.Front Immunol2026https://conductscience.org/library/papers/42199421PubMed
42180976Ferroptosis-related lncRNA signature predicts prognosis and treatment response in colon cancer.Transl Cancer Res2026https://conductscience.org/library/papers/42180976PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41454405

GET https://conductscience.org/api/papers/v1/41454405/references?page=2